Cowen Prime Advisors LLC 13D and 13G filings for HTG Molecular Diagnostics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-03 4:02 pm Sale | 2022-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM | Cowen Prime Advisors LLC | 0 0.000% | -7,117,596 (Position Closed) | Filing |
| 2023-02-03 3:11 pm Unchanged | 2022-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM | Cowen Prime Advisors LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-09 12:34 pm Purchase | 2021-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM | Cowen Prime Advisors LLC | 7,117,596 8.000% | 7,117,596 (New Position) | Filing |